Sonia Carparelli

An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors

Sara Onali, Daniela Pugliese, Flavio Caprioli et al. · The American Journal of Gastroenterology · 2022 · 49 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy

Michele Francesco Chiappetta, Anna Viola, Mauro Mastronardi et al. · Expert Opinion on Biological Therapy · 2021 · 38 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs

Fabrizio Bossa, Sonia Carparelli, Anna Latiano et al. · Digestive and Liver Disease · 2021 · 21 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Accuracy and inter-observer agreement of the nice and kudo classifications of superficial colonic lesions: a comparative study

Francesco Cocomazzi, Marco Gentile, Francesco Perri et al. · International Journal of Colorectal Disease · 2021 · 15 citations

Medicine, Pathology, Surgery +14

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study

Cristina Bezzio, Alessandro Armuzzi, Federica Furfaro et al. · Alimentary Pharmacology & Therapeutics · 2021 · 14 citations · Full text

Medicine, Immunology, Infectious Diseases +16